San Francisco, California, October 18, 2017: A recent business and commerce study by TMR Research notifies that the global market for immunotherapy drugs is healthy, and that the demand will continue to increment at a notable CAGR throughout the forecast period of 2017 to 2025, primarily driven by increasing adoption of targeted therapy over traditional therapy. The report, compiled by a group of professional market research analysts, aspires to serve as a business tool for its targeted audiences such as pharmaceutical manufacturers, hospitals and specialty clinics, research and academic institutions, contract manufacturers, and contract research organizations. The report explores all market dynamics including drivers, restraints, trends, and opportunities, segments it into small aspects, takes stock of the potential of various important regions and countries, and profiles some of the key companies currently owing position of strength in the global immunotherapy drugs market.
As per the findings of the report, targeted therapies have gained popularity among the urban population of developed economies as they have fewer side-effects. In addition to that, the immunotherapy market is gaining traction from several other factors, such as growing prevalence of cancer and autoimmune diseases, increase in the demand for mAbs, rise in the percentage of geriatric population, mushrooming specialty clinics that offer patient assistance programs, and a promising pipeline that are highly likely to gain approvals. On the other hand, patent expiries of top-selling drugs, adverse effects of these drugs, high cost of biologicals that hinders its expansion in developing regions, and stringent regulations are some of the challenges obstructing the prosperity of the immunotherapy drugs market. The report analyzes some of the key trends of this market, such as emergence of targeted and combination therapies, increase in awareness programs, strategic alliances, emergence of biosimilars, and expected entry of novel vaccines.
Based on type, the global immunotherapy drugs market can be segmented into immune checkpoint inhibitors, vaccines, and non-specific immunotherapies. On the basis of therapy area, the market can be bifurcated into cancer including solid tumor and malignant, autoimmune and inflammatory diseases, and infectious diseases. Based on drugs, the market for immunotherapy drugs can be categorized into adult vaccines, monoclonal antibodies, interleukins, interferons Alpha and beta, and checkpoint inhibitors. Geographically, the report takes stock of the potential of immunotherapy drugs market in every important region and country such as North America including the U.S. and Canada, Asia Pacific including India, China, Japan, and Australia, Europe including the U.K., France, and Germany, and the Middle East and Africa.
As per the findings of the report, the global immunotherapy drugs market is highly competitive in nature with a large number of players participating in it. Most of these vendors ooze from widespread geographical presence and actively undergo strategic alliances to share manufacturing and marketing capabilities. Some of the key companies currently operating in the global immunotherapy drugs market are AbbVie, Bristol-Myers Squibb, Amgen, F.Hoffmann-La Roche, Merck, Johnson & Johnson, AstraZeneca, Baxter, Eli Lilly, and Sanofi.
The aim of this intelligence report is to represent quantitative and qualitative analysis of the global immunotherapy drugs market. Beginning with an overview of dynamics such as drivers, restraints, trends, and opportunities, the report offers a detailed scenario of the market that has been built via primary research and secondary research. Primary investigation formed the bulk of the research efforts undertaken to collate the report, included data sourced from e-mail interactions, personal interviews, and telephonic interviews. On the other hand, secondary research efforts utilized while creating the report involved the thorough analysis of annual reports, company websites, stock analysis presentations, a number of national and international databases, and press releases. The report provides market size for all key segments across key regional markets in terms of US$ mn/bn over the period between 2017 and 2025, considering several micro- and macro-economic factors influencing the overall growth prospects of the market.
Click on the link below to request a sample copy of the report